Skip to Main Content

Walgreens Boots Alliance (WBA), one of the largest retail pharmacies in the U.S., has agreed to pay $269 million to the federal and state governments to settle allegations of fraudulently overdispensing insulin pens and violating the False Claims Act for billing Medicaid at rates higher than its usual rates for certain prescription drugs.

In the first instance, the retailer did not always adhere to the dosage that was prescribed by physicians for insulin pens and, instead, dispensed boxes containing five pens, regardless of patient needs. As a result, Medicare and Medicaid beneficiaries routinely received more insulin than prescribed and Walgreens billed Medicaid for the additional doses, according to court documents.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Ed,
    I don’t get it Ed !! Please tell me why there are one set of rules for big corporate
    chain pharmacies and different rules for independent pharmacies ? Is it because they own the PBM’s that are fleecing this country too? There isn’t one congressman or senator that sees this and wants to do the right thing for America ? Can you please show this article and my response to Donald !!!!!!!!!!!

Comments are closed.